ArticleCancer medicine2023

Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapy.

Xibin Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.